Nina Karpoff
Chief Business & Strategy Officer & Co-Founder RNARevive
Nina Karpoff is Chief Business & Strategy Officer at RNARevive Inc., a Canadian biotech developing next-generation self-amplifying RNA (saRNA) therapeutics for durable protein expression. She leads corporate strategy, fundraising, partnerships, and commercialization. Together with Dr. Asghar Fallah, RNARevive’s scientific founder and inventor of the company’s saRNA platform, she is bringing this technology to life and advancing it toward clinical and commercial translation.
Seminars
Thursday 28th May 2026
Redesigning Self-Amplifying RNA to Enable Durable, Low-Dose In Vivo Therapeutic Reprogramming
3:30 pm
- Extend therapeutic expression from days to months by redesigning intracellular control of self-amplifying RNA to support sustained, low-frequency dosing beyond vaccine-optimized kinetics
- Expand saRNA applicability into chronic and tissue-specific indications by overcoming rapid clearance and homogeneous expression through synthetic biology modification of UTRs and replicase machinery
- Enable scalable, cost-effective alternatives to ex vivo cell therapies and complex biologics by positioning in vivo saRNA-driven reprogramming as a practical therapeutic platform for osteoporosis, ophthalmology, and rare diseases
